BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim YK, LaFon D, Nahm MH. Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease. Infect Chemother 2016;48:257-66. [PMID: 28032483 DOI: 10.3947/ic.2016.48.4.257] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Yoo JR, Oh S, Lee JG, Kim YR, Lee KH, Heo ST. Invasive Pneumococcal Disease Caused by Non-Vaccine Type Multidrug-Resistant Streptococcus pneumoniae Transmitted by Close Contact in a Healthy Adult. Yonsei Med J 2019;60:1103-7. [PMID: 31637893 DOI: 10.3349/ymj.2019.60.11.1103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Shafie AA, Ahmad N, Naidoo J, Foo CY, Wong C, Pugh S, Tan KK. Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation. Hum Vaccin Immunother 2020;16:1719-27. [PMID: 31951782 DOI: 10.1080/21645515.2019.1701911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zhou H, He J, Wu B, Che D. Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants. Hum Vaccin Immunother 2018;14:1444-52. [PMID: 29425054 DOI: 10.1080/21645515.2018.1438794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Bloom DE, Kirby PN, Pugh S, Stawasz A. Commentary: Why Has Uptake of Pneumococcal Vaccines for Children Been So Slow? The Perils of Undervaluation. Pediatric Infectious Disease Journal 2020;39:145-56. [DOI: 10.1097/inf.0000000000002521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
5 Bedeley E, Gori A, Yeboah-Manu D, Diallo K. Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae. Front Microbiol 2021;12:658824. [PMID: 33967998 DOI: 10.3389/fmicb.2021.658824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kim JH, Baik SH, Chun BC, Song JY, Bae IG, Kim HY, Kim DM, Choi YH, Choi WS, Jo YM, Kwon HH, Jeong HW, Kim YS, Kim JY, Lee J, Kee SY, Hur J, Chung JW, Hwang KE, Kim MJ. Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group. Int J Infect Dis 2018;74:136-44. [PMID: 30055332 DOI: 10.1016/j.ijid.2018.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
7 Chang B, Kinjo Y, Morita M, Tamura K, Watanabe H, Tanabe Y, Kuronuma K, Fujita J, Oshima K, Maruyama T, Abe S, Kasahara K, Nishi J, Kubota T, Ohnishi M, Suga S, Oishi K. Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan. Front Cell Infect Microbiol 2021;11:617573. [PMID: 33869075 DOI: 10.3389/fcimb.2021.617573] [Reference Citation Analysis]
8 Kang J, Kim EH, Ihn K, Jung I, Han M, Ahn JG. Risk of invasive pneumococcal disease in patients with asplenia/hyposplenism: A nationwide population-based study in Korea, 2009–2018. International Journal of Infectious Diseases 2020;98:486-93. [DOI: 10.1016/j.ijid.2020.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nisar MI, Ahmed S, Jehan F, Shahid S, Shakoor S, Kabir F, Hotwani A, Munir S, Muhammad S, Khalid F, Althouse B, Hu H, Whitney C, Ali A, Zaidi AKM, Omer SB, Iqbal N. Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan. Vaccine 2021;39:1319-27. [PMID: 33422379 DOI: 10.1016/j.vaccine.2020.12.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Manna S, Ortika BD, Dunne EM, Holt KE, Kama M, Russell FM, Hinds J, Satzke C. A novel genetic variant of Streptococcus pneumoniae serotype 11A discovered in Fiji. Clin Microbiol Infect 2018;24:428.e1-7. [PMID: 28736074 DOI: 10.1016/j.cmi.2017.06.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
11 von Mollendorf C, Ulziibayar M, Gessner BD, Do LAH, Nguyen CD, Beavon R, Suuri B, Luvsantseren D, Narangerel D, Jenney A, Dunne EM, Satzke C, Darmaa B, Mungun T, Mulholland EK. Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study. BMC Public Health 2021;21:1731. [PMID: 34556065 DOI: 10.1186/s12889-021-11776-8] [Reference Citation Analysis]
12 Froes F, Roche N, Blasi F. Pneumococcal vaccination and chronic respiratory diseases. Int J Chron Obstruct Pulmon Dis 2017;12:3457-68. [PMID: 29255353 DOI: 10.2147/COPD.S140378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
13 Kim EY, Kim SH, Kim GR, Shin JH. Characteristics of Clonal Complex Changes and Quinolone Resistance-Determining Region Mutations of Levofloxacin-Resistant Streptococcus pneumoniae in South Korea. Microb Drug Resist 2022. [PMID: 35325563 DOI: 10.1089/mdr.2021.0341] [Reference Citation Analysis]